ANDA 77899, held by Ph Health. Nifedipine.
As of Nov 16, 2026, ANDA 77899 (Nifedipine), held by Ph Health, was first approved by FDA on Dec 13, 2006, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 13, 2006 | Original application | Approved | None posted |
| Nifedipine30MG · tablet, extended release;oral | Nifedipine | Discontinued |
| Nifedipine60MG · tablet, extended release;oral | Nifedipine | Discontinued |
| Nifedipine90MG · tablet, extended release;oral | Nifedipine | Discontinued |
| Sep 10, 2014 | Supplement 9Labeling | Approved | None posted |
| May 25, 2012 | Supplement 8Labeling | Approved | None posted |
| Apr 29, 2011 | Supplement 17Labeling | Approved | None posted |
| Nov 30, 2010 | Supplement 16Labeling | Approved | None posted |
| Dec 13, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters